Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …

Background and Purpose—The use of bare metal stents to treat symptomatic intracranial
stenosis may be associated with significant restenosis rates. The advent of drug-eluting …

Importance Prior randomized trials have generally shown harm or no benefit of stenting
added to medical therapy for patients with symptomatic severe intracranial atherosclerotic …

Importance Intracranial stenosis is one of the most common etiologies of stroke. To our
knowledge, no randomized clinical trials have compared balloon-expandable stent …

Background and Purpose—Intracranial stenting is associated with a 32% rate of restenosis.
Drug-eluting stents (DES) have revolutionized the treatment of coronary artery disease and …

OBJECTIVE: To report the 1-month and intermediate-term results of treatment of
symptomatic intracranial stenosis using drug-eluting stents. BACKGROUND: Patients with …

BACKGROUND: Stenting for symptomatic intracranial atherosclerotic disease is a
therapeutic option in patients in whom medical therapy fails. OBJECTIVE: To determine the …

Objective: To test whether symptomatic severe intracranial atherosclerotic stenosis was
associated with a higher subsequent stroke risk than moderate stenosis after elective …

Background and Purpose—Angioplasty and stenting is increasingly being used for the
treatment of intracranial stenoses. Based on a literature search (01/1998 to 04/2008) we …

Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke that
is increasingly being treated with percutaneous transluminal angioplasty and stenting …